Logo image of ILAG

INTELLIGENT LIVING APPLICATI (ILAG) Stock Fundamental Analysis

NASDAQ:ILAG - Nasdaq - KYG4804S1012 - Common Stock - Currency: USD

0.3805  +0.01 (+1.47%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ILAG. ILAG was compared to 41 industry peers in the Building Products industry. The financial health of ILAG is average, but there are quite some concerns on its profitability. ILAG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ILAG has reported negative net income.
ILAG had a negative operating cash flow in the past year.
ILAG had negative earnings in each of the past 5 years.
In the past 5 years ILAG always reported negative operating cash flow.
ILAG Yearly Net Income VS EBIT VS OCF VS FCFILAG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -2M -4M -6M -8M

1.2 Ratios

ILAG has a Return On Assets of -17.98%. This is amonst the worse of the industry: ILAG underperforms 90.24% of its industry peers.
With a Return On Equity value of -20.71%, ILAG is not doing good in the industry: 85.37% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -17.98%
ROE -20.71%
ROIC N/A
ROA(3y)-13.9%
ROA(5y)-13.76%
ROE(3y)-23.27%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
ILAG Yearly ROA, ROE, ROICILAG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -10 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 12.79%, ILAG is doing worse than 92.68% of the companies in the same industry.
In the last couple of years the Gross Margin of ILAG has grown nicely.
The Profit Margin and Operating Margin are not available for ILAG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.3%
GM growth 5Y7.66%
ILAG Yearly Profit, Operating, Gross MarginsILAG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

More info and screens

5

2. Health

2.1 Basic Checks

ILAG does not have a ROIC to compare to the WACC, probably because it is not profitable.
ILAG has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ILAG has about the same amount of shares outstanding.
Compared to 1 year ago, ILAG has an improved debt to assets ratio.
ILAG Yearly Shares OutstandingILAG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M 15M
ILAG Yearly Total Debt VS Total AssetsILAG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of 1.65, we must say that ILAG is in the distress zone and has some risk of bankruptcy.
ILAG has a Altman-Z score of 1.65. This is amonst the worse of the industry: ILAG underperforms 82.93% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that ILAG is not too dependend on debt financing.
ILAG has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. ILAG outperforms 82.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 1.65
ROIC/WACCN/A
WACC10.06%
ILAG Yearly LT Debt VS Equity VS FCFILAG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 6.74 indicates that ILAG has no problem at all paying its short term obligations.
The Current ratio of ILAG (6.74) is better than 92.68% of its industry peers.
A Quick Ratio of 3.61 indicates that ILAG has no problem at all paying its short term obligations.
ILAG's Quick ratio of 3.61 is amongst the best of the industry. ILAG outperforms 95.12% of its industry peers.
Industry RankSector Rank
Current Ratio 6.74
Quick Ratio 3.61
ILAG Yearly Current Assets VS Current LiabilitesILAG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

ILAG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.53%, which is quite impressive.
ILAG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -36.28%.
ILAG shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.88% yearly.
EPS 1Y (TTM)34.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.23%
Revenue 1Y (TTM)-36.28%
Revenue growth 3Y-16.88%
Revenue growth 5Y-14.88%
Sales Q2Q%131.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ILAG Yearly Revenue VS EstimatesILAG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 5M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ILAG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ILAG Price Earnings VS Forward Price EarningsILAG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ILAG Per share dataILAG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ILAG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTELLIGENT LIVING APPLICATI

NASDAQ:ILAG (4/30/2025, 8:13:58 PM)

0.3805

+0.01 (+1.47%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)11-29 2022-11-29/bmo
Earnings (Next)N/A N/A
Inst Owners0.18%
Inst Owner Change0%
Ins Owners51.83%
Ins Owner ChangeN/A
Market Cap6.87M
AnalystsN/A
Price TargetN/A
Short Float %1.37%
Short Ratio0.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.77
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.49
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.5
BVpS0.78
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.98%
ROE -20.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.79%
FCFM N/A
ROA(3y)-13.9%
ROA(5y)-13.76%
ROE(3y)-23.27%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.3%
GM growth 5Y7.66%
F-Score3
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 76.35%
Cap/Sales 6.76%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.74
Quick Ratio 3.61
Altman-Z 1.65
F-Score3
WACC10.06%
ROIC/WACCN/A
Cap/Depr(3y)531.11%
Cap/Depr(5y)342.82%
Cap/Sales(3y)18.52%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.23%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-36.28%
Revenue growth 3Y-16.88%
Revenue growth 5Y-14.88%
Sales Q2Q%131.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-111.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.04%
OCF growth 3YN/A
OCF growth 5YN/A